OTTO DAWN PARSELL (Sr VP, Clinical Development) sold 94.3% of their position (4.25K shares) of TRICIDA, INC. on the open market
Open‑market sale worth $133.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.25K
Price / share
$1.68
Trade value
$2.10K
% of position
Common Stock
Shares
−1.25K
Price / share
$29.98
Trade value
$37.48K
% of position
Common Stock
Shares
+210.00
Price / share
$1.68
Trade value
$352.80
% of position
Common Stock
Shares
−210.00
Price / share
$31.98
Trade value
$6.72K
% of position
Common Stock
Shares
+1.74K
Price / share
$1.68
Trade value
$2.93K
% of position
Common Stock
Shares
−1.74K
Price / share
$31.98
Trade value
$55.77K
% of position
Common Stock
Shares
+523.00
Price / share
$2.39
Trade value
$1.25K
% of position
Common Stock
Shares
−523.00
Price / share
$31.98
Trade value
$16.73K
% of position
Common Stock
Shares
+523.00
Price / share
$7.49
Trade value
$3.92K
% of position
Common Stock
Shares
−523.00
Price / share
$31.98
Trade value
$16.73K
% of position
Net shares
+0.00
Net value
-$122.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/28/2020 | M · Option Exercise | +1.25K | $1.68 | $2.10K | 490.2% | 255.00 | 1.50K |
| Common Stock Direct | 4/28/2020 | S · Sale | −1.25K | $29.98 | $37.48K | 83.1% | 1.50K | 255.00 |
| Common Stock Direct | 4/29/2020 | M · Option Exercise | +210.00 | $1.68 | $352.80 | 82.4% | 255.00 | 465.00 |
| Common Stock Direct | 4/29/2020 | S · Sale | −210.00 | $31.98 | $6.72K | 45.2% | 465.00 | 255.00 |
| Common Stock Direct | 4/29/2020 | M · Option Exercise | +1.74K | $1.68 | $2.93K | 683.9% | 255.00 | 2K |
| Common Stock Direct | 4/29/2020 | S · Sale | −1.74K | $31.98 | $55.77K | 87.2% | 2K | 255.00 |
| Common Stock Direct | 4/29/2020 | M · Option Exercise | +523.00 | $2.39 | $1.25K | 205.1% | 255.00 | 778.00 |
| Common Stock Direct | 4/29/2020 | S · Sale | −523.00 | $31.98 | $16.73K | 67.2% | 778.00 | 255.00 |
| Common Stock Direct | 4/29/2020 | M · Option Exercise | +523.00 | $7.49 | $3.92K | 205.1% | 255.00 | 778.00 |
| Common Stock Direct | 4/29/2020 | S · Sale | −523.00 | $31.98 | $16.73K | 67.2% | 778.00 | 255.00 |
| Total | +0.00 | -$122.87K | ||||||
Employee Stock Option (right to buy)
Common Stock
1.25K shares
Shares
−1.25K
Strike price
1.68
Held after
7.56K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
210.00 shares
Shares
−210.00
Strike price
1.68
Held after
630.00
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
1.74K shares
Shares
−1.74K
Strike price
1.68
Held after
5.82K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
523.00 shares
Shares
−523.00
Strike price
2.39
Held after
17.27K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
523.00 shares
Shares
−523.00
Strike price
7.49
Held after
23.56K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock1.25K shares | 4/28/2020 | M · Option Exercise | −1.25K | 1.68 | — | 7.56K |
| Employee Stock Option (right to buy) Direct | Common Stock210.00 shares | 4/29/2020 | M · Option Exercise | −210.00 | 1.68 | — | 630.00 |
| Employee Stock Option (right to buy) Direct | Common Stock1.74K shares | 4/29/2020 | M · Option Exercise | −1.74K | 1.68 | — | 5.82K |
| Employee Stock Option (right to buy) Direct | Common Stock523.00 shares | 4/29/2020 | M · Option Exercise | −523.00 | 2.39 | — | 17.27K |
| Employee Stock Option (right to buy) Direct | Common Stock523.00 shares | 4/29/2020 | M · Option Exercise | −523.00 | 7.49 | — | 23.56K |